Krystal Biotech, Inc.KRYSNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+11.0%
5Y CAGR+26.5%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+11.0%/yr
vs +52.9%/yr prior
5Y CAGR
+26.5%/yr
Recent deceleration
Acceleration
-42.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.2x
Strong expansion
Streak
9 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$58.05M+8.3%
2024$53.57M+15.4%
2023$46.43M+9.3%
2022$42.46M+52.3%
2021$27.88M+55.5%
2020$17.94M+14.9%
2019$15.62M+101.2%
2018$7.76M+141.9%
2017$3.21M+332.9%
2016$741000.00-